bilical cord severance, periodontitis, &/or recurrent soft tissue infections were identified. Adhesion-dependent PMN functions (chemotaxis, adherence-spreading, aggregation, phagocytosis, orientation, 8 antibody-dependent cellular cytotoxicity) were significantly (p <.001 for each assay) diminished in each pt. All fathers, mothers o; sib1 ings ( 2 M, 1 F) were asymptomatic 8 demonstrated normal PMN functions. PMN homogenates of each patient demonstrated a severe deficiency ( < 5 $ normal) of a high M.W. gl ycoprotein (GP138) (SDS-PAGE). A N~B~H I , label l ing technique indicated that GP138 represents a major surface GP complex of normal PMNs (11.457 ug/mg total protein), but was undetectable on the surface of pt PMNs. GP138 content of maternal or female sib1 ing PMNs was diminished (mean = 3.3 pg/mg), but was norma.1 (mean = 13.6 ug/mg) in paternal or male sibling suspensions.
Monoclonal antibodies directed at the a 8 common B subunits of 3 leukocyte "adhesive" GPs (OKMI, LFA-1, P150,95) were employed to demonstrate the absence of each of these GPs on the surface of patient PMNs 8 diminished (10-50% normal) surface OKMl 8 6 on maternal or female siblings' P M N s ' ( f 1 microfluorimetry). Thus, GP138 deficiency syndrome represents a new disorder(s) related to the absence of criticai adhesive PMN GPs. Since males 8 females are affected 8 the carrier state can be detected only in females, its mode of genetic transmission is uncertain.
RING 21 CHROMOSOME: WCALIWTION OF TEE BREAKPOINTS
739 WHHIN A 2 KB DNA FRAGMENT. s t y 1 ianos E.
Antonarrkis, James F. Gusella, Gail S t e t t e n , Michael We have studied cells from a patient who was followed with a diagnosis of spastic cerebral palsy until the age of 9 years when he was found to have a deficiency of hypoxanthine phosphoribosyltransferase (HPRT). He has dysarthria, choreathetoid movements, and an lQ in the normal range. He is nonambulatory because of the spastici ty and has not engaged in self-muti lation other than some scratching and nai i biting. Autoradiography of his cultured skin fibroblasts after exposure to 3~-hypoxanthin 2 revealed a frequency of HPRT' cells in the range of 10.5 to 10-.
His cells were cloned in 6-thioguanine and then grown in the absence of sele tive medium. The frequency of HPRT' cel Is ranged from to 3~10.5 after approximately 23 cell doubling. Cells exposed to 3~-h~~o x a n t h i n e in the presence of aminopterin showed significant low level uptake in all cells indicating that these cells ail contain some HPRT activity.
Cei Is were grown in HAT medium and clones of HAT-resistant cel Is were isolates. A sensitive HPLC assay for HPRT has been developed to study enzyme activity in these cel Is. The milder phenotype of the patient may be related to cells that are spontaneously reverting to HPRT' as well as to the low background level of HPRT in all cells.
A TWO HOUR PHENYLALANINE (P) LOAD FOR CARRIER DETFC-
. , --.-. Since the enzymatic determination of P-hydroxylase activlty remains limited to liver tissue, the diagnosis of most PKU homozygotes and especially heterozygotes relies on P-loading tests. In the present study, plasma was obtained before a P load (t=O) and a various time intervals after the load. The P and T concentrations in plasma were determined using a Beckman 6300 Amino Acid Analyzer. Twenty-five controls, 20 obligate heterozygotes and 10 patients with PKU were studied. The most informative parameters were obtained from values at t=O, 60 and 90 minutes. Age weig$t, the use of birth control pills, values of P, T, PIT, p/T2, PIT , the natural log of these parameters, and their various transformations were subjected to discriminant analysis with the statistical program BMDP7M. The various ratios for PKll homozygotes were 1-2 orders of magnitude higher than those of controls and heterozygotes. The analysis at t=O (as suggested by some authors) revealed a 14.8% misclassification for heterozygotes. The best discrimination using 1 blood sample was at 60 minutes; only 1 of the controls was misclassified (3.7%). When females on birth control pills were excluded and using the variables of age, P/T at t=O and 60 minutes, the function correctly classified all individuals. This procedure enabled the best discrimination between heterozygotes and controls thus far described. Baylor College of Medicine, Department of Pediatrics, Hollston.
TION OF PHENYLKETONURIA (PKU

TRANS-ACTING REGULATION
We are attempting to delineate the molecular basis for both metabolite regulation of AS and enzyme overproduction in canavanine resistant (Canr) cells. We isolated normal and Canr variant lymphoblast cell lines from the parent of a citrullinemia patient. These cells contain one normal gene and one mutant allele producing an abnormal mRNA which is distinguishable by S1 nuclease analysis. Activities for AS (nmol/min/mg proteid) were as follows: lymphoblasts in arginine medium <0.01; lymphoblasts in citrulline medium 0.05; three Canr lymphoblast variants 0.79-1.2. S1 nuclease analysis demonstrated parallel increases in both normal and abnormal RNA in the Canr cells in proportion to the increase in enzyme activity. Since selective pressure in the Canr isolation is restricted to the functional allele, the increased expression of the mutant allele must reflect a trans-acting mechanism affecting the expression of both alleles. We also have detected alternative RNA splicing involving the presence or absence of an exon (probably the 2nd exon) in the 5' untranslated region of the mRNA. This exon is present in only a very minor proportion of mRNA from human liver or fibroblasts, but is present in a larger proportion of mRNA from Canr cells or baboon liver. The functional significance of this result is unclear at present. A fatty acid abnomlity has been suggested for cystic fibrosis (CF) kause CF secretions h e 1) excess htty acids bound to glycoprotein and 2) high levels of leukotrienes, a specific group of htty acids. Carnitine transports fatty acids into mitochondria where they are oxidized. S e m free z d xyl camitines in 10 CF patients averaged 46.27 and 6.35 nrol/ml respectively, ad cculd m t be distiwished £ran control levels. m e r , the basis for the research was that excess carnitine may irrrease phumary metabolism of fatty acids. We have given oral camitine to 3 CF patients with recent clinical deterioration and 6 stable CF patients.
L-WWITRE
Sick patients with inspissated secretions and recent decreased pubnary £unction showed greatest improvement in pulmonary function (FEV 1 and FVC) 6 1 5 days after beginning 3-4 grams of carnitine per day. Jmprovmt xes dramtic (&O-lM)%). Broncbspasm improved in the 2 patients tho dmcmtrated it. Positive effects were not permanent, hmver, and pllmry hction began to deteriorate i n 2 of 3 patients after 6 ~e k s of therapy. ll-ry filnction did not improve significantly in 5 of 6 older, stable patients with cystic fibrosis then 3-4 gradday of camitine was given for 3 raeks. kwver, all patients had loosening of secretions and 4 of 6 reprted improved ability to cough. Although sweat sodium appeared to decrease in 4 of 6 patients, the results were variable and no consistent pattern xes observed.
lhese studies suggest pat L-camitine may have useful short term effects in acutely ill patients with CF.
